303810.KQ DK Life Science Co., Ltd.

Healthcare Medical Instruments & Supplies KOSDAQ
2,095 KRW
Close of Oct 30, 2026
2,040 4,110
Market cap
KRW 67.0B
P/E
13.8x
P/B
0.50x
ROE
2.1%
Dividend yield
-
Fundamental score
2.3/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 303810.KQ undervalued?

Graham number
Price2,095
Graham value3,766
Discount44.4%

303810.KQ trades 44.4% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DK Life Science Co., Ltd. fundamental analysis

12 of 22 checks passed

ROE 0/2

Low return on equity (2.1%), below 10%.

ROA 1/1

Return on assets (1.3%) is above the industry median (-2.3%).

Profit Consistency 1/2

Profitable for 4 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (285.7%) is above the industry median (-27.9%).

Revenue Growth 1/2

Revenue grew 6.7% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (2.6%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

No interest expense reported.

PE vs Market 0/1

PE (13.8x) is above the market median (11.3x).

PE vs Industry 1/1

PE (13.8x) is below the industry median (30.3x).

PBV 1/1

Price to book (0.5x) is below the industry median (1.2x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 7.0, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

DK Life Science Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DK Life Science Co., Ltd.

DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science C…

Full company profile